0

    544409

    ASTONEALAB

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ASTONEA LABS LIMITED Share Price Today

    Investment Returns

    Over 1 Month 5.36% Over 3 Months 71.09% Over 6 Months 72.54% Over 1 Year 56.56%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ASTONEA LABS LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 287.70
    • P/E Ratio (TTM) 63.66
    • Beta 0.39
    • Book Value / share 54.35
    • Return on equity 11.97%
    • EPS (TTM) 4.30
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text

    ASTONEA LABS LIMITED Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 147.58
    Operating Expense 142.48
    Net Profit 4.52
    Net Profit Margin (%) 3.06
    Earnings Per Share (EPS) 4.49
    EBITDA 13.87
    Effective Tax Rate (%) 19.75
    Particulars MAR 2025 (Values in Cr)
    Revenue 97.52
    Operating Expense 90.64
    Net Profit 5.35
    Net Profit Margin (%) 5.48
    Earnings Per Share (EPS) 6.94
    EBITDA 15.31
    Effective Tax Rate (%) 24.32
    Particulars MAR 2024 (Values in Cr)
    Revenue 80.19
    Operating Expense 74.91
    Net Profit 4.07
    Net Profit Margin (%) 5.07
    Earnings Per Share (EPS) 5.36
    EBITDA 12.01
    Effective Tax Rate (%) 24.34
    Particulars MAR 2023 (Values in Cr)
    Revenue 67.05
    Operating Expense 66.17
    Net Profit 0.67
    Net Profit Margin (%) 0.99
    Earnings Per Share (EPS) 1.66
    EBITDA 7.33
    Effective Tax Rate (%) 38.88
    Particulars MAR 2022 (Values in Cr)
    Revenue 30.06
    Operating Expense 29.59
    Net Profit 0.25
    Net Profit Margin (%) 0.83
    Earnings Per Share (EPS) 0.62
    EBITDA 5.87
    Effective Tax Rate (%) 56.89
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 54.35
    ROE % 11.97
    ROCE % 10.47
    Total Debt to Total Equity 1.28
    EBITDA Margin 9.50
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 23.85
    ROE % 29.06
    ROCE % 15.12
    Total Debt to Total Equity 2.90
    EBITDA Margin 15.87
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 54.35
    ROE % 11.97
    ROCE % 10.47
    Total Debt to Total Equity 1.28
    EBITDA Margin 9.50
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 23.85
    ROE % 35.35
    ROCE % 17.21
    Total Debt to Total Equity 3.16
    EBITDA Margin 15.87
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 15.60
    ROE % 40.66
    ROCE % 16.90
    Total Debt to Total Equity 3.92
    EBITDA Margin 14.99
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 20.39
    ROE % 7.54
    ROCE % 8.01
    Total Debt to Total Equity 4.19
    EBITDA Margin 10.71
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 18.73
    ROE % 3.34
    ROCE % 5.83
    Total Debt to Total Equity 3.94
    EBITDA Margin 19.79
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 0.17
    Total Assets 146.26
    Total Liabilities 146.26
    Total Equity 57.13
    Share Outstanding 1
    Price to Book Ratio 2.82
    Return on Assets (%) 3.08
    Return on Capital (%) 4.51
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.08
    Total Assets 103.38
    Total Liabilities 103.38
    Total Equity 18.41
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.17
    Return on Capital (%) 7.46
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.08
    Total Assets 103.38
    Total Liabilities 103.38
    Total Equity 18.41
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.17
    Return on Capital (%) 7.46
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.35
    Total Assets 80.71
    Total Liabilities 80.71
    Total Equity 11.85
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.04
    Return on Capital (%) 7.5
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 64.27
    Total Liabilities 64.27
    Total Equity 8.15
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.03
    Return on Capital (%) 1.51
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 52.91
    Total Liabilities 52.91
    Total Equity 7.49
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.47
    Return on Capital (%) 0.67
    Particulars MAR 2025 (Values in Cr)
    Net Income 7.07
    Cash from Operations 12.71
    Cash from Investing -11.14
    Cash from Financing 1.62
    Net change in Cash -0.27
    Free Cash Flow 23.50
    Particulars MAR 2024 (Values in Cr)
    Net Income 5.37
    Cash from Operations 9.82
    Cash from Investing -8.34
    Cash from Financing -0.26
    Net change in Cash -0.75
    Free Cash Flow 17.28
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.08
    Cash from Operations -0.65
    Cash from Investing -3.08
    Cash from Financing 4.13
    Net change in Cash 0.00
    Free Cash Flow 2.46
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.57
    Cash from Operations -4.36
    Cash from Investing -3.31
    Cash from Financing 8.17
    Net change in Cash -0.06
    Free Cash Flow -1.02
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 14.47 1.68 267.22 23.12 38.85
    BLISS GVS PHARMA LTD. 467.40 37.63 4.16 4965.84 118.35 552.90
    CIPLA LTD 1472.95 33.25 3.45 118991.58 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 501.25 23.44 3.62 1475.23 256.40 507.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 24.38 4.49 267.22 23.12 38.85
    AMRUTAJAN HEALTH LTD 515.00 23.08 4.02 1488.90 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8103.65 105.90 23.21 20259.13 7630.00 9850.00
    BLISS GVS PHARMA LTD. 467.40 50.58 4.29 4965.84 118.35 552.90

    ASTONEA LABS LIMITED shareholding pattern

    Holding
    27.62%
    72.3%
    0.06%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    ASTONEA LABS LIMITED Technicals Summary

    273.75 0.00 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 270.90
    • 26 Days 263.40
    • 10 Days 271.30
    • 50 Days 244.30
    • 12 Days 271.00
    • 100 Days 216.70
    • 20 Days 267.60
    • 200 Days 193.80
    273.75 PIVOT
    First Support 273.75 First Resistance 273.75 Second Support 273.75 Second Resistance 273.75 Third Support 273.75 Third Resistance 273.75
    RSI 57.55 ADX 20.79 MACD 7.61 Williams % R -47.85 Commodity Channel Index (CCI) 28.74
    Date 2026-07-29 Week 1400.00 Same Day 1000.00 Month 2789.00
    1 Year 0.39 3 Year 0.33
    Over 1 Month
    5.36% down
    Over 1 Year
    56.56% down
    Over 3 Months
    71.09% down
    Over 3 Years
    0.00% down
    Over 6 Months
    72.54% down
    Over 5 Years
    0.00% down

    ASTONEA LABS LIMITED Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Astonea Labs Ltd?

    Answer Field

    Astonea Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 273.75 as on Aug 03 2026 02:36 PM.

    What is the Market Cap of Astonea Labs Ltd Share?

    Answer Field

    The market cap of Astonea Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 287.70 as on Aug 03 2026 02:36 PM.

    What is the 52 Week High and Low of Astonea Labs Ltd?

    Answer Field

    The 52 Week High and Low of Astonea Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 301.30 and ₹ 118.00.

    What is 1 year return for Astonea Labs Ltd?

    Answer Field

    The 1 year returns on the stock has been 56.56%.

    What is the P/E Ratio of Astonea Labs Ltd Share?

    Answer Field

    As on Aug 03 2026 02:36 PM the price-to-earnings (PE) ratio for Astonea Labs Ltd share is 63.66.

    What is the PB ratio of Astonea Labs Ltd Share?

    Answer Field

    As on Aug 03 2026 02:36 PM, the price-to-book (PB) ratio for Astonea Labs Ltd share is 54.35.

    How to Buy Astonea Labs Ltd Share?

    Answer Field

    You can trade in Astonea Labs Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Astonea Labs Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Astonea Labs Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Astonea Labs Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |